ConductScience.org, home

Paper697347

Activity of 5-episisomicin compared with that of other aminoglycosides.

Fu KP and 1 other. Antimicrob Agents Chemother, 1978. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Activity of 5-episisomicin compared with that of other aminoglycosides. Papers, record 697347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/697347

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Activity of 5-episisomicin compared with that of other aminoglycosides.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fu KPK P
2Neu HCH C

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
GentamicinsMajor topic
SisomicinMajor topic
Aminoglycosides
Bacillus
Drug Synergism
Enterobacteriaceae
Gram-Negative Aerobic Bacteria
Microbial Sensitivity Tests
Staphylococcus aureus
Streptococcus

Source PubMed

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,829In vitro study of netilmicin compared with other aminoglycosides.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/10829PubMed
2416,011Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells.J Antibiot (Tokyo)1978https://conductscience.org/library/papers/416011PubMed
3626,490Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/626490PubMed
4791,104In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/791104PubMed
5787,451Tobramycin: an overview.J Infect Dis1976https://conductscience.org/library/papers/787451PubMed
64,581,231Mechanisms of antibiotic resistance in bacteria.Annu Rev Biochem1973https://conductscience.org/library/papers/4581231PubMed
74,468,277Mutamicins; biosynthetically created new sisomicin analogues.J Antibiot (Tokyo)1974https://conductscience.org/library/papers/4468277PubMed
8166,284Aminoglycoside-modifying enzymes.Methods Enzymol1975https://conductscience.org/library/papers/166284PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
6,967,2965-epi-Sisomicin and 5-epi-Gentamicin B: substrates for aminoglycoside-modifying enzymes that retain activity against aminoglycoside-resistant bacteria.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6967296PubMed
6,775,590UK31214, a new aminoglycoside and derivative of kanamycin B.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6775590PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/697347

GET https://conductscience.org/api/papers/v1/697347/authors